However, as the patient tumor datasets contain a wide variety of cell types including immune, endothelial, and fibroblast cells, these cells were first removed from our analysis based on the expression of PTPRC (CD45), ESM1, and TAGLN respectively [57, 58]. This evidence concerns the gene TAGLN and neoplasm.